Clinical feature	Statistical test	Significant genes	Associated with	               	Associated with	
Time to Death	Cox regression test	N=3027	shorter survival	N=1360	longer survival	N=1667
AGE	Spearman correlation test	N=3544	older	N=1692	younger	N=1852
PRIMARY SITE OF DISEASE	ANOVA test	N=17276	 	 	 	 
GENDER	t test	N=9002	male	N=4105	female	N=4897
KARNOFSKY PERFORMANCE SCORE	Spearman correlation test	N=274	higher score	N=164	lower score	N=110
HISTOLOGICAL TYPE	ANOVA test	N=16527	 	 	 	 
PATHOLOGY T	Spearman correlation test	N=5428	higher pT	N=2925	lower pT	N=2503
PATHOLOGY N	Spearman correlation test	N=12	higher pN	N=4	lower pN	N=8
PATHOLOGICSPREAD(M)	ANOVA test	N=33	 	 	 	 
TUMOR STAGE	Spearman correlation test	N=7068	higher stage	N=3772	lower stage	N=3296
RADIATIONS RADIATION REGIMENINDICATION	t test	N=5808	yes	N=2873	no	N=2935
NEOADJUVANT THERAPY	t test	N=7886	yes	N=4017	no	N=3869